Skip to main content
Measles, mumps and rubella vaccination target for five year olds in England has been met for the first time

* NHS Digital must be quoted as the source of these figures

* Regional figures are available

20 Sept 2017

The proportion of eligible children receiving their first dose of the Measles, Mumps and Rubella vaccine (MMR1) by their fifth birthday has met the World Health Organisation target of 95 per cent for the first time in England in 2016-17.

Statistics published today by NHS Digital1, show that the proportion of children receiving the MMR1 vaccine by age five has increased year on year since 2006-07. Coverage was 95.0 per cent in 2016-17 compared with 94.8 per cent for 2015-16.

Coverage of the MMR1 vaccine by children's second birthday has decreased in 2016-17 for the third year in a row to 91.6 per cent.

Childhood Vaccination Coverage Statistics 2016-172 include national coverage figures for routine childhood vaccinations, which are offered to all children up to the age of five3.

Other routine vaccinations included in the report are DTaP/IPV/Hib (also referred to as the 5-in-1 vaccine), pneumococcal conjugate vaccine (PCV), and the children's flu vaccine.

According to the report, 93.4 per cent of children received the 5-in-1 vaccine before their first birthday in 2016-17, which is a decrease from 93.6 per cent last year and 94.2 per cent in 2014-15.

This is the first year that national coverage figures for the rotavirus vaccine have been included in the report. Figures show that 89.6 per cent of children in England received the rotavirus vaccine before their first birthday during 2016-17.

Experimental statistics4 for the meningococcal B (MenB)5 vaccine have also been included for the first time.

Regional breakdowns are available in the report and show a variation in coverage across the country. Levels of immunisation for 10 out of the 12 routine childhood vaccinations covered by the report were highest in the North East. London had the lowest immunisation coverage for all 12 routine childhood vaccinations included in the report.

The 2016-17 report is accompanied by a new interactive data dashboard which has been developed in collaboration with Public Health England.

This dashboard enables users to drill down to local authority level and examine both local and national trends in greater detail.

Accessibility statement

This tool is in Microsoft PowerBI which does not fully support all accessibility needs. If you need further assistance, please contact us for help.

Childhood Vaccination Coverage Statistics 2016-17 are available on the NHS Digital website.


Notes to editors

1. NHS Digital is the national information and technology provider for the health and care system. Our team of information analysis, technology and project management experts create, deliver and manage the crucial digital systems, services, products and standards upon which health and care professionals depend. During the 2016/17 financial year, NHS Digital published 292 statistical reports. Our vision is to harness the power of information and technology to make health and care better. The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital. We provide 'Information and Technology for better health and care'. Find out more about our role and remit

2. Following user feedback, we have changed the title of this publication from 'NHS Immunisations Statistics, England' to 'Childhood Vaccination Coverage Statistics, England'as this more accurately reflects the content within the report. The publication has featured data on childhood vaccinations only, since the adult flu data were last published as part of it in 2014-15. The statistics show the number of children vaccinated as a proportion of the eligible population (coverage), and are derived from information collected by Public Health England through the Cover of Vaccination Evaluated Rapidly (COVER) and Seasonal Influenza programmes.

3. Coverage data supplied at:

12 months:

· Diphtheria, tetanus, pertussis, polio, and Haemophilus influenza type B vaccine (DTaP/IPV/Hib - commonly known as the "5 in 1" vaccine)

· Meningococcal group B (MenB) vaccine (experimental statistics)

· Pneumococcal conjugate vaccine (PCV)

· Rotavirus vaccine

· Hepatitis B vaccine

· Bacillus Calmette-Guérin vaccine (BCG)

24 months:

· Diphtheria, tetanus, pertussis, polio and Haemophilus influenza type B vaccine (DTaP/IPV/Hib)

· Haemophilus influenza type B and meningococcal group C (Hib/MenC) booster vaccine

· Pneumococcal conjugate vaccine (PCV) booster

· Measles-mumps-rubella (MMR) vaccine

· Hepatitis B vaccine

· Childhood influenza vaccine

Three years:

· Childhood influenza vaccine

Four years:

· Childhood influenza vaccine

Five years:

· Diphtheria, tetanus, pertussis and polio vaccine (DTap/IPV pre-school booster)

· Measles-mumps-rubella (MMR) vaccine

· Haemophilus influenzae type B and meningococcal group C (Hib/MenC) vaccine

4. Experimental statistics are a series of statistics that are in the testing phase and not yet fully developed. A key part of the "experimental statistics" label is user engagement in the evaluation of those statistics. NHS Digital invites readers to comment on the experimental statistics in this report, and send user feedback to

5. Due to data quality issues we have published Men B figures at local authority level for the one year cohort as experimental statistics. There are no national or regional Men B figures published for this cohort.

6. Coverage figures are presented as percentages and are rounded to one decimal place.

Last edited: 24 May 2021 2:45 pm